Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.WT | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by Sunvalleyon Sep 23, 2022 7:47am
208 Views
Post# 34981104

RE:RE:Financing

RE:RE:Financing
In my view , the financing was clearly a positive. Minimal dilution , $ in hand to proceed ,and the financing issue is laid to rest for a good long while. Now the company can proceed with the business at hand and that is a cure for Cancer. Another 10 million or 17 million shares is peanuts if these efforts are sucessful. Anyone who is making a issue of further dilution should not be here if they really put things into perspective. If you want to take issue with real dilution , study how the countries of the world are now printing money to fund their excesses, especially the United States. That should keep you busy for a while.Or look at some of the large pharmaceuticals with many hundreds of millions or a billion plus shares outstanding , while trading over $100.00 a share plus.  Three hundred  million shares outstanding is lunch money if TLT reaches their goals which are now a possibility. For what it is worth, my reaction was to buy the dip. GLTA.
<< Previous
Bullboard Posts
Next >>